SRAX INC (SRAX)
US78472M1062 - Common Stock
We assign a fundamental rating of 3 out of 10 to SRAX. SRAX was compared to 276 industry peers in the Software industry. While SRAX seems to be doing ok healthwise, there are quite some concerns on its profitability. SRAX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
SRAX had negative earnings in the past year.
SRAX had a negative operating cash flow in the past year.
In the past 5 years SRAX reported 4 times negative net income.
SRAX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The profitability ratios for SRAX are negative, so there is not much use analyzing them.
SRAX has a better Return On Invested Capital (0.04%) than 73.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 0.04% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SRAX's Operating Margin of 0.05% is fine compared to the rest of the industry. SRAX outperforms 73.06% of its industry peers.
Looking at the Gross Margin, with a value of 73.34%, SRAX is in the better half of the industry, outperforming 70.03% of the companies in the same industry.
SRAX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.05% | ||
| PM (TTM) | N/A | ||
| GM | 73.34% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.58%
GM growth 5Y16.6%
2. Health
2.1 Basic Checks
SRAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SRAX has been increased compared to 1 year ago.
SRAX has a better debt/assets ratio than last year.
2.2 Solvency
SRAX has an Altman-Z score of 0.23. This is a bad value and indicates that SRAX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SRAX (0.23) is worse than 67.00% of its industry peers.
There is no outstanding debt for SRAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.23 |
ROIC/WACC0
WACC10.1%
2.3 Liquidity
A Current Ratio of 1.13 indicates that SRAX should not have too much problems paying its short term obligations.
SRAX's Current ratio of 1.13 is on the low side compared to the rest of the industry. SRAX is outperformed by 71.72% of its industry peers.
A Quick Ratio of 1.13 indicates that SRAX should not have too much problems paying its short term obligations.
SRAX's Quick ratio of 1.13 is on the low side compared to the rest of the industry. SRAX is outperformed by 71.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
SRAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.18%, which is quite impressive.
SRAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 109.34%.
SRAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.67% yearly.
EPS 1Y (TTM)42.18%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q123.2%
Revenue 1Y (TTM)109.34%
Revenue growth 3Y39.3%
Revenue growth 5Y-5.67%
Revenue growth Q2Q37.85%
3.2 Future
The Earnings Per Share is expected to grow by 50.52% on average over the next years. This is a very strong growth
SRAX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.17% yearly.
EPS Next Y124.58%
EPS Next 2Y50.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.07%
Revenue Next 2Y-5.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SRAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 1.95, the valuation of SRAX can be described as very cheap.
Based on the Price/Forward Earnings ratio, SRAX is valued cheaper than 100.00% of the companies in the same industry.
SRAX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1.95 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -65.27 |
4.3 Compensation for Growth
SRAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SRAX's earnings are expected to grow with 50.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.52%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for SRAX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SRAX INC
NASDAQ:SRAX (3/8/2023, 7:07:58 PM)
After market: 0.62 +0.02 (+3.33%)0.6
-0.98 (-62.03%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.79M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1.95 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 0.05% | ||
| PM (TTM) | N/A | ||
| GM | 73.34% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)42.18%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y124.58%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)109.34%
Revenue growth 3Y39.3%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y